Introduction
Thrombotic complications are common in the nephrotic syndrome. These have been attributed to a hypercoagulable state."2 Venous thrombosis is well recognized, but arterial thrombosis occurs less frequently and is seen primarily in children. 3 We report two patients with the nephrotic syndrome who developed arterial thrombosis, and discuss the pathogenesis, management and the prophylaxis of this potentially serious condition.
Case 1
A 27 year old man with an 18-month history of mesangioproliferative glomerulonephritis and nephrotic syndrome presented with excruciating pain in both lower legs and inability to walk, which began after a long train journey. He smoked about 15-20 cigarettes a day. His only medication was frusemide. Examination revealed that both calves were tender and swollen, and both feet were cold and pale. The pedal pulses were absent. Bilateral leg venography were negative, but bilateral femoral arteriography showed thrombus in both profunda femoralis and distal popliteal arteries.
Investigations showed a protein C antigen activity of 138% (75-155). Protein S antigen activity of 82% (50-150), plasminogen activity of 135% (75-125), fibrinogen 13.1 g/l (1.5-4 g/l) and antithrombin III antigen activity of 55% (80-155). Haemoglobin was 16.5 g/dl, haematocrit 48.6%, leucocyte count 21.2 x 109/1, neutrophils 14 .8 x 109/1 and platelet count 318 x 109/l. Plasma viscosity was 2.14 cp (1.5-1.72) and ESR 1 5 mm/ 1 hour. Blood urea was 8.3 mmol/l, serum creatinine 95 pmol/l, serum albumin 18 g/l and with a 24 hours protein excretion of 36 g. Antinuclear antibodies, anti-DNA antibody, anticardiolipin antibodies and lupus anticoagulant were negative. He was treated with analgesia and anti-coagulation with reperfusion of the lower limbs and resolution of the pain. He was in remission 18 months later.
Case 2
A 47 year old female with a 6 month history of mesangioproliferative glomerulonephritis and the nephrotic syndrome presented with a painful right leg. She smoked 10 cigarettes a day. Her medications were frusemide and prednisolone. On examination she had cold and blue oedematous feet with absent right femoral, popliteal and pedal pulses. Arteriogram revealed a thrombus causing a complete block in her right iliac inflow together with fairly severe femoro distal occlusive disease.
Investigations revealed a haemoglobin of 15.9 g/ dl, haematocrit 42% and a leucocyte count 22.4 x 10-9/l, platelets count 420 x 10-9/l. Blood urea was 9.4 mmol/l, serum creatinine 134 jimol/l, 
Aspirin
There is growing evidence that aspirin may be useful in reducing the risks of thromboembolic disease in the nephrotic syndrome. In a model of arterial thrombosis induced by laser, a partial occlusion was induced in small mesenteric arterioles. Thrombus formed within seconds after the laser lesion and grew rapidly. Embolization began within the minute following the laser flash. The administration of aspirin at three doses (50, 100 and 200 mg/kg) by intramuscular injection, 15 min before the laser injury, induced three different phenomena: (1) an increase of the number of laser injuries required for the thrombus formation; (2) a dose-dependent decrease in the duration ofembolization; and (3) a dose-dependent decrease in the number of emboli.4' In another aspirin-sensitive model of arterial thrombosis in anaesthetized rats, carotid artery thrombi were formed in response to electrical stimulation and were occlusive in 84% of vehicle-treated rats. Among other anti-thrombotic drugs, intravenous administration of aspirin (10 mg/kg) decreased average thrombus weight by 35% and also reduced the frequency ofocclusion to less than 25%. 42 Reduction ofproteinuria Serum albumin below 25 g/l is a statistically significant risk factor for venous (40.0 versus 2.7%; P<0.01) and for combined arterial and venous (28.6 versus 5.5%; P < 0.01) episodes of thromboembolism.' A low serum albumin is inversely correlated with fibrinogen'7 and correlated with anti-thrombin 111,1,17 and increased platelet aggregability. These abnormalities can be reduced by the normalization of serum albumin.24 An attempt to reduce the degree of proteinuria should be made in these patients. Angiotensin-converting enzyme inhibitors are effective in reducing proteinuria by decreasing glomerular filtration pressure.43 Their effect is increased if they are accompanied by a salt-restricted diet. Non-steroidal anti-inflammatory drugs also reduce the proteinuria by reducing the renal blood flow and glomerular filtration rate,44 therefore they must not be used in patients with renal impairment.
Drug administration Diuretics, the mainstay of therapy in nephrotic oedema should be used with caution and only if oedema persists in spite of salt restriction. The judicious use of salt-poor albumin and diuretic infusion in severe cases reduces the risks of plasma volume depletion, haemoconcentration and thromboembolic complications. Steroid administration increases the concentrations of several clotting factors and modifies the coagulation mechanisms.3 Thus these agents should be used cautiously in the treatment of the nephrotic syndrome.
Arterial hypertension
Arterial hypertension, as discussed earlier, constitutes a risk factor for arterial thrombosis and should be treated vigorously, aiming at a diastolic pressure of less than 90 mmHg. Angiotensin-converting enzyme inhibitors are useful in the treatment of hypertension because of their ability to reduce proteinuria and retard progressive glomerular sclerosis.
Hyperlipidaemia
There is a suggestion that hyperlipidaemia may be responsible for platelet hyperaggregability as platelet aggregability is increased in type II hyperlipoproteinemia to a degree that is comparable to that seen in the nephrotic syndrome.34 Reduction of dietary saturated fats and cholesterol, and the administration of the newer and safer anti-lipidaemia drugs, for example, hydroxy-methylglutaryl coenzyme A (HMG CoA) can reverse the nephrotic hyperlipidaemia and thus decrease the platelet hyperaggregability, reducing the risk of thrombosis.
Endothelium and atherosclerosis
Tobacco, diabetes, and obesity contribute to atherosclerosis. Refraining from smoking, control of weight and diabetes mellitus, if present, is of utmost importance in reducing the risk of atherosclerosis, thus minimizing endothelial damage and possible arterial thrombosis. Thrombosis in our patients was multifactorial and related partly to the prothombotic tendency associated with a nephrotic syndrome as evident by the low level of anti-thrombin III and the raised fibrinogen level. This is related to the hypoalbuminaemia and the massive proteinuria, particularly in the first patient. Other possible contributing factors to the thrombosis are the hyperlipidaemia and smoking in both patients, the use of diuretics, the stasis and immobility suffered by the first patient during the long trainjourney, and the use of diuretics and corticosteroids in the second patient.
Conclusion
Thrombosis in general and arterial thrombosis in particular is a significant and potentially serious problem in nephrotic patients. Awareness of the condition is needed. Assessment for the risk factors is required to allow appropriate prophylactic measures to be taken. nephrotic syndrome. 
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